Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Smoking cessation

Experts warn against e-cigarettes

    • Education
    • General Internal Medicine
    • Pneumology
    • RX
  • 3 minute read

According to current data, there is no proven long-term benefit of using e-cigarettes for smoking cessation. The switch to electronic substitutes is merely a shift in addictive behavior and poses health risks of unknown proportions, experts warn.

Contrary to the opinion of some addiction researchers, e-cigarettes are not a suitable tool for people who want to quit smoking altogether, concludes the German Society for Pneumology and Respiratory Medicine.

Call for a ban on advertising of electronic smoking products

Several studies have shown that students who use e-cigarettes are also more likely to use conventional cigarettes [1]. In the USA, cases of acute respiratory failure and death have been published after the use of e-cigarettes [2]. Therefore, the DGP warns against the use of e-cigarettes, especially by adolescents. Young people are a popular target group for advertising campaigns by the cigarette industry, in which smoking is portrayed as a lifestyle factor. For reasons of youth protection, too, the expert therefore calls for a complete ban on advertising for both traditional tobacco and e-cigarettes.

It is a widespread misconception that electronic vaporizers are significantly less harmful to health than conventional tobacco cigarettes. What is not mentioned: depending on the type of e-cigarette and the composition of the liquid used, harmful substances can be inhaled, such as propylene glycol (irritating to the respiratory tract), formaldehyde (carcinogenic) or lead, chromium and nicotine.  In addition, the flavoring substances used pose a variety of health hazards [3,4]. In a recent review, the acute potential adverse health effects, which particularly affect the lungs and respiratory tract, are noted [5]. “The long-term effects of e-cigarette use cannot be fully assessed at this stage. However, the findings to date show that these devices pose a considerable health risk. It is therefore negligent and irresponsible of the cigarette industry to sell e-cigarettes as a harmless, modern alternative,” Prof. Michael Pfeifer, MD, President of the DGP. “The industry is focusing on the lifestyle factor in its advertising, appealing primarily to young people for whom e-cigarettes represent a low-threshold entry point into nicotine addiction.” – Prof. Pfeifer.

Cessation programs instead of e-cigarette

In a recent statement, the European Respiratory Society (ERS) also opposes the downplaying of the dangers of e-cigarettes [6]. In addition, the ERS also disagrees with the repeated claim that e-cigarettes have a positive benefit in helping smokers quit. Although a meta-analysis of several longitudinal studies on the efficacy of e-cigarettes had shown that they had a short-term positive cessation effect under controlled clinical conditions. However, in the long term and under real-life conditions, they make smoking abstinence more difficult. The most sensible way to get permanently without nicotine is through structured cessation programs, according to Prof. Tobias Welte, MD, past-president of the ERS.

 

Literature:

  1. Morgenstern M, Nies A, Goecke M, Hanewinkel R: E-cigarettes and initiation of conventional cigarette use – A cohort study in grade 10 adolescents. Dt. Physicians Journal 2018; 115: 243-248.
  2. Layden JE, Ghinai I, Pray I, et al: Pulmonary illness related to e-cigarette use in Illinois and Wisconsin – preliminary report. N Engl J Med 2019, Sep 6; DOI: 10.1056.
  3. Jabba S, Jordt SE: Risk analysis for the carcinogen pulegone in mint- and menthol-flavored e-cigarettes and smokeless tobacco products. JAMA Intern Med 2019, Sep 16. DOI: 10.1001.
  4. Bitzer Z, Goel R, Reilly S, et al: Effect of flavoring chemicals on free radical formation in electronic cigarette aerosols, Free Radic Biol Med 2018; 120: 72-79.
  5. Gotts JE, Jordt SE, McConnell R, Tarran R: What are the respiratory effects of e-cigarettes? BMJ. 2019 Sep 30; 366: l5275. DOI: 10.1136/bmj.l5275.
  6. European Respiratory Society, Tobacco Control Committee: position paper on tobacco harm reduction (translated by DGP). August 2019.

 

HAUSARZT PRAXIS 2019; 14(11): 34

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • addictive behavior
  • Cigarettes
  • E-cigarettes
  • Smoking cessation
Previous Article
  • Acute coronary syndrome

Utility of fSENC MRI in the acute setting.

  • Cardiology
  • Congress Reports
  • RX
View Post
Next Article
  • Psoriasis and cardiovascular comorbidities.

Complex interaction structure: Implications for therapy

  • Cardiology
  • Congress Reports
  • Dermatology and venereology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 23 min
  • Important basics and studies on cancer and the psyche

Interplay between cancer and mental illness

    • CME continuing education
    • Oncology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 5 min
  • Systemic lupus erythematosus

Increased risk of pulmonary manifestations

    • Education
    • General Internal Medicine
    • Pneumology
    • Rheumatology
    • RX
    • Studies
View Post
  • 6 min
  • Postmenopausal osteoporosis: long-term therapy concepts

Targeted use of antiresorptives and osteoanabolic agents and avoid “rebound” effects

    • Congress Reports
    • General Internal Medicine
    • Gynecology
    • Orthopedics
    • Pharmacology and toxicology
    • RX
View Post
  • 6 min
  • Late-onset rheumatoid arthritis

More DMARDs can reduce glucocorticoids in LORA

    • Education
    • Pharmacology and toxicology
    • Rheumatology
    • RX
    • Studies
View Post
  • 8 min
  • Atopic dermatitis

Implement the “minimal disease activity” concept

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 6 min
  • Sensation of pain

Special features for people with multiple disabilities

    • Congress Reports
    • General Internal Medicine
    • Neurology
    • Pediatrics
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 14 min
  • Prevention of skin cancer

UV protection and skin cancer screening – Update 2025

    • CME continuing education
    • Dermatology and venereology
    • Interviews
    • Oncology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 12 min
  • Atopic dermatitis

Clinic, therapy and prevention in early childhood

    • Allergology and clinical immunology
    • CME continuing education
    • Dermatology and venereology
    • Infectiology
    • Pediatrics
    • Prevention and health care
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Interplay between cancer and mental illness
  • 2
    UV protection and skin cancer screening – Update 2025
  • 3
    Clinic, therapy and prevention in early childhood
  • 4
    Hyponatremia in the outpatient setting
  • 5
    Hurdles to pain treatment for autistic patients

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.